Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Elvira Gerbino"'
Autor:
Valentina Tabanelli, Federica Melle, Giovanna Motta, Saveria Mazzara, Marco Fabbri, Chiara Corsini, Elvira Gerbino, Angelica Calleri, Maria Rosaria Sapienza, Ignazio Abbene, Viviana Stufano, Massimo Barberis, Stefano A. Pileri
Publikováno v:
Haematologica, Vol 105, Iss 8 (2020)
Externí odkaz:
https://doaj.org/article/85977b4d86fc45b99ce7e10f81a16109
Autor:
Maria Rosaria Sapienza, Federica Melle, Elvira Gerbino, Marco Fabbri, Chiara Corsini, Angelica Calleri, Stefano Pileri, Ignazio Abbene, Saveria Mazzara, Giovanna Motta, Massimo Barberis, Valentina Tabanelli, Viviana Stufano
Publikováno v:
Haematologica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b814061d8bdf0027dc7dbcf9f5ab92f
https://europepmc.org/articles/PMC7395260/
https://europepmc.org/articles/PMC7395260/
Autor:
Omar Malazzi, P. Giuseppe Pelicci, Andrea Viale, María D. Odero, Francesco Bertolini, Cinzia Tapinassi, Elena Belloni, Valentina Dall'Olio, D. Shing, Elvira Gerbino, Patrizia Mancuso, I. Egurbide
Publikováno v:
Leukemia. 25:733-736
In vivo expression of an aberrant MYB-GATA1 fusion induces leukemia in the presence of GATA1 reduced levels
Publikováno v:
British Journal of Haematology. 142:551-561
Heat shock proteins (HSPs) are a super family of highly conserved molecular chaperone proteins, which are induced in response to stress. HSP70 has been demonstrated to inhibit apoptosis induced by a number of chemotherapeutic agents. Previous investi
Autor:
Paola Marighetti, Ines Martin Padura, Elvira Gerbino, Stefania Orecchioni, Pier Giuseppe Pelicci, Fulvia Fusar Imperatore, Francesco Bertolini, Giovanni Bertalot, Elena Belloni
Publikováno v:
Scientific Reports
A role for bone-marrow-derived cells (BMDCs) in tissue repair and malignancy onset has been proposed, but their contribution is still debated. We tested the ability of BMDCs containing the inducible krasV12 oncogene to initiate lung adenocarcinoma. F
Autor:
Kuichun Zhu, Melissa Alsina, Andrew D. Hamilton, Said M. Sebti, Carlos A. Muro-Cacho, Paul A. Mackley, Darrin M. Beaupre, Elvira Gerbino, William S. Dalton, Mathias G. Lichtenheld, Craig A. Beam, William G. Kerr
Publikováno v:
Blood. 105:4759-4766
Despite major advances, multiple myeloma (MM) remains an incurable malignancy. Recently we have found that disease stabilization was achieved in 64% of patients with advanced MM treated with the farnesyltransferase inhibitor R115777 (Zarnestra) in a
Autor:
Elvira Gerbino, Alex A. Adjei, Daniel M. Sullivan, Said M. Sebti, Scott H. Kaufmann, Rose M. Overton, Melissa Alsina, Tammy Price-Troska, Benjamin Djulbegovic, Rafael Fonseca, William S. Dalton, Philip R. Greipp, Laura M. Bruzek, Alan B. Cantor, John J. Wright, Gregory J. Ahmann, A. Nelida Belle, Edward C. F. Wilson
Publikováno v:
Blood. 103:3271-3277
Patients with multiple myeloma (MM) with mutated RAS are less likely to respond to chemotherapy and have a shortened survival. Therefore, targeting RAS farnesylation may be a novel approach to treatment of MM. We evaluated the activity and tolerabili
Autor:
Małgorzata Z. Zdzienicka, Suh-Chin J. Lin, Yosef Shiloh, Song Zhao, Jerry W. Shay, Yael Ziv, Eva Y.-H. P. Lee, Mei-hua Song, Yi-Chinn Weng, Elvira Gerbino, Shyng Shiou F Yuan, Richard A. Gatti, Hao-Chi Hsu, Yi-Tzu Lin
Publikováno v:
Nature. 405:473-477
Ataxia-telangiectasia (A-T) and Nijmegen breakage syndrome (NBS) are recessive genetic disorders with susceptibility to cancer and similar cellular phenotypes1. The protein product of the gene responsible for A-T, designated ATM, is a member of a fam
Autor:
María José Calasanz, Elvira Gerbino, María D. Odero, Elena Belloni, Patrizia Gasparini, Jose' M. Beltran-Heredia, Pier Giuseppe Pelicci, Cinzia Tapinassi, Omar Malazzi, Carla Micucci
Publikováno v:
Cancer Genetics and Cytogenetics. 195:198-200
Autor:
Elvira Gerbino, Giovanna Meloni, Robert Foa, Lucia Brandimarte, Elena Belloni, Silvia Maria Trisolini, P. G. Pelicci, Valentina Pierini, Barbara Crescenzi, M F Martelli, R La Starza, Christina Mecucci, Mauro Nanni, M.Z. Limongi, Cinzia Tapinassi, Paolo Gorello
Publikováno v:
Leukemia. 22:216-218
A PDGFRB -positive acute myeloid malignancy with a new t(5;12)(q33;p13.3) involving the ERC1 gene